Biomarkers Market value worth USD 46.12 billion 2020 | Market Data ForecastPosted by rohan on May 22nd, 2018 Biomarkers Market Value and Growth Analysis: Biomarkers market is expected to reach USD 46.12 billion by 2020 from USD 24.55 billion in 2015, growing at a CAGR of 13.44% during the forecast period 2015-2020. Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery and development processes and assessment of disease conditions. Browse market data tables and in-depth TOC of the Biomarkers Market to 2020 @ https://www.marketdataforecast.com/market-reports/global-biomarkers-market-192/ Biomarkers Market Drivers and Restraints: Increasing research and development spending, rising healthcare expenditure, and growing demand for biomarkers in the diagnostic field are driving the growth of global biomarkers market. In addition, increasing number of low cost of clinical trials in emerging countries, growth initiatives in biomarkers research, increasing growth of information technology, growing demand for drug discovery are further propelling the growth of global biomarkers market. However, the requirement of high investment, improper reimbursement policies, poor regulatory bodies, the high cost of testing procedures, and difficulties in sample collection & storage are the major factors restraining the growth of global biomarkers market. Biomarkers Market Segment The Market is segmented based on the product, type, application, and disease indications. Based on product, the market is further sub-segmented as consumables, software, and services. Based on the type, the market is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the market is segmented as cancer, cardiovascular, neurological, and immunological disorders. Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/global-biomarkers-market-192/request-sample Regional Analysis On the basis of the geographical region, the global biomarkers market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America held the major market share of 39.0% of the global biomarkers market in 2015, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.20% during the forecast period 2015-2020. Biomarkers Market Competitors Analysis The key players in global biomarkers industry include Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.). The scope of the report provides:
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest. About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions. Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206
Like it? Share it!More by this author |